Armata Pharmaceuticals

$4.49
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.66 (-12.82%) Today

$0.00 (0.00%) As of 11:00 PM UTC after-hours

Why Robinhood?

You can buy or sell ARMP and other stocks, options, and ETFs commission-free!

About ARMP

Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company focused on the development of bacteriophage therapeutics for antibiotic-resistant infections using its proprietary bacteriophage-based technology. Its product candidate is the AP-SA01 that targets Staphylococcus aureus, including multidrug-resistant strains. The company was founded on May 9, 2019 and is headquartered in Los Angeles, CA. The listed name for ARMP is Armata Pharmaceuticals, Inc. Common Stock.

CEO

Todd R. Patrick

Employees

Headquarters

Los Angeles, California

Founded

2019

Market Cap

100.26M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

38.34K

High Today

$5.26

Low Today

$4.28

Open Price

$5.05

Volume

56.99K

52 Week High

$10.48

52 Week Low

$2.52

ARMP Earnings

-$0.73

-$0.49

-$0.24

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 18, After Hours